NCEL
NewcelX Ltd.
NASDAQ: NCEL · HEALTHCARE · BIOTECHNOLOGY
$3.42
+2.09% today
Updated 2026-04-29
Market cap
$17.27M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.93
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.5
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-50.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Altman Z -50.26 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-2.07M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net income | $-11.95M | $-16.50M | $-12.17M | $-1.98M | $-2.22M |
| EPS | — | — | — | — | $-6.93 |
| Free cash flow | $-14.98M | $-14.52M | $-9.68M | $-4.27M | $-2.07M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
NewcelX Ltd. trades at $3.42. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -50.26, it sits in the distress.
Frequently asked questions
What is NewcelX Ltd.'s stock price?
NewcelX Ltd. (NCEL) trades at $3.42.
Is NewcelX Ltd. overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of NewcelX Ltd. (NCEL)?
The analyst target price is $—, representing NaN% downside from the current price of $3.42.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-50.26 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE—
Beta0.57
50D MA$2.74
200D MA$9.54
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—